Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice
Evelyn Saba, Chun Hee Lee, Da Hye Jeong, Kija Lee, Tae-Hwan Kim, Seong-Soo Roh, Seung-Hyung Kim, Man Hee Rhee
Fermented rice bran prevents atopic dermatitis in DNCB-treated NC/Nga mice
The fermentation of natural plants has a favorable effect on the functional and biological activities of living systems. These include anti-oxidative, anti-inflammatory, and anti-platelet aggregation activities. This is attributed to the chemical conversion of the parent plants to functional constituents, which show more potent biological activity. In our study, rice bran along with oriental medicinal plants (Angelicae gigantis, Cnidium officinale, Artemisia princeps, and Camellia sinensis) was fermented by Lactobacillus rhamnosus and Pichia deserticola (FRBE). We evaluated the effects of oral administration of FRBE on atopic dermatitis in 1-chloro-2,4-dinitrobenzene (DNCB)-treated NC/Nga mice. FRBE significantly ameliorated the macroscopic and microscopic appearance of skin lesions in DNCB-induced atopic dermatitis and reduced levels of serum immunoglobulin E and the differential white blood cell count. In addition, it reduced skin thickness compared to that of atopic dermatitis-affected skin. FRBE treatment also reduced mast cell incorporation in skin lesions of atopic dermatitis. The total cell number in dorsal skin tissue and the axillary lymph node increased following DNCB application, and this was normalized by FRBE treatment. Moreover, it decreased the levels of CD8+ helper T cells and Gr-1+/CD11b+ B cells in peripheral blood mononuclear cells and skin lesions in DNCB-induced atopic dermatitis. Using real-time polymerase chain reaction analysis, we demonstrated that FRBE significantly inhibited mRNA expression of cytokines (e.g., interleukin-5 and interleukin-13) and cyclooxygenase-2 in AD skin lesions. These results suggest that FRBE could be a valuable herbal remedy for the treatment of atopic dermatitis.
fermentation / rice bran / gas chromatography / Lactobacillus rhamnosus / Pichia deserticola
[1] |
Thomsen SF. Atopic dermatitis: natural history, diagnosis, and treatment[J]. ISRN Allergy, 2014, 2014: 354250.
|
[2] |
Mansouri Y, Guttman-Yassky E. Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics[J]. J Clin Med , 2015, 4(5): 858–873
Pubmed
|
[3] |
Pastore S, Mascia F, Giustizieri ML,
Pubmed
|
[4] |
Kim K. Influences of Environmental Chemicals on Atopic Dermatitis[J]. Toxicol Res , 2015, 31(2): 89–96
Pubmed
|
[5] |
Bradding P, Roberts JA, Britten KM,
Pubmed
|
[6] |
Sokol CL, Barton GM, Farr AG,
Pubmed
|
[7] |
Izuhara K, Arima K, Yasunaga S. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies[J]. Curr Drug Targets Inflamm Allergy , 2002, 1(3): 263–269
Pubmed
|
[8] |
Ryan EP, Heuberger AL, Weir TL,
Pubmed
|
[9] |
Chung SY, Seo YK, Park JM,
Pubmed
|
[10] |
Choi JY, Paik DJ, Kwon DY,
Pubmed
|
[11] |
Sohn Y, Lee HS, Park HJ,
Pubmed
|
[12] |
Lee SH, Lee JH, Oh EY,
Pubmed
|
[13] |
Ryu R, Jung UJ, Kim HJ,
Pubmed
|
[14] |
Kim TH, Lee SJ, Rim HK,
Pubmed
|
[15] |
Liu J, Xing J, Fei Y. Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies[J]. Chin Med , 2008, 3: 12
Pubmed
|
[16] |
Park BK, Park YC, Jung IC,
Pubmed
|
[17] |
Saunders SP, Moran T, Floudas A,
Pubmed
|
[18] |
Takahashi-Ando N, Jones MA, Fujisawa S,
Pubmed
|
[19] |
Choopani R, Mehrbani M, Fekri A,
Pubmed
|
[20] |
Park BK, Park YC, Jung IC,
Pubmed
|
[21] |
Jeon BR, Ji HD, Kim SJ,
|
[22] |
Biedermann T, Skabytska Y, Kaesler S,
Pubmed
|
[23] |
Liu FT, Goodarzi H, Chen HY. IgE, mast cells, and eosinophils in atopic dermatitis[J]. Clin Rev Allergy Immunol, 2011, 41(3): 298–310
Pubmed
|
[24] |
Jankovic D, Feng CG. CD4(+) T Cell Differentiation in Infection: Amendments to the Th1/Th2 Axiom[J]. Front Immunol, 2015, 6: 198
Pubmed
|
[25] |
Hennino A, Vocanson M, Toussaint Y,
Pubmed
|
[26] |
Hijnen D, Knol EF, Gent YY,
Pubmed
|
[27] |
Li J, Shen C, Liu Y,
Pubmed
|
[28] |
Yagi R, Nagai H, Iigo Y,
Pubmed
|
[29] |
Gu CY, Gu L, Dou X. Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis[J]. Int J Dermatol , 2015, 54(7): e261–e265
Pubmed
|
/
〈 | 〉 |